{
  "meta": {
    "title": "41_Acute_Lymphocytic_Leukemia",
    "url": "https://brainandscalpel.vercel.app/41-acute-lymphocytic-leukemia-aa6ecbcb.html",
    "scrapedAt": "2025-11-30T17:52:20.049Z"
  },
  "questions": [
    {
      "text": "Adult T cell leukemia is caused by which of the following viruses?",
      "choices": [
        {
          "id": 0,
          "text": "HTLV-1"
        },
        {
          "id": 1,
          "text": "EBV"
        },
        {
          "id": 2,
          "text": "HPV"
        },
        {
          "id": 3,
          "text": "Polyoma virus"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: HTLV-1</strong></p>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following is not correct about CNS leukemia?",
      "choices": [
        {
          "id": 0,
          "text": "LP is restricted to patients with platelet count less than 20K /cu mm"
        },
        {
          "id": 1,
          "text": "Intrathecal methotrexate to be given after performing lumbar puncture"
        },
        {
          "id": 2,
          "text": "LP is routine diagnostic test during work up of patient of ALL"
        },
        {
          "id": 3,
          "text": "Cell count > 5 cells/uL or leukemic blast cells on morphology is diagnostic"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: LP is restricted to patients with <span class=\"customMeta\" data-dictid=\"e7032bae7f1692777195d693722e54\">platelet</span> count less than 20K/cu mm</strong></p>\n\n<h3> </h3>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 10-year-old patient presents with fatigue and bleeding. Peripheral blood shows anaemia, thrombocytopenia and neutropenia. Bone marrow flow cytometry shows blasts positive for both CD19, CD79a , CD13, CD33, along with cytoplasmic myeloperoxidase. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 0,
          "text": "B cell ALL"
        },
        {
          "id": 1,
          "text": "T cell ALL"
        },
        {
          "id": 2,
          "text": "Biphenotypic ALL"
        },
        {
          "id": 3,
          "text": "AML"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct answer is c: Biphenotypic ALL</strong></p>\n\n<ul>\n\t<li>Biphenotypic leukemias express markers of both <span class=\"customMeta\" data-dictid=\"32599f889a169277719169e3483e62\">lymphoid</span> and <span class=\"customMeta\" data-dictid=\"da88d7f2211692777193037caba514\">myeloid</span> lineages on the same leukemic cells.</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following is correct about complete molecular response in patients with ALL?",
      "choices": [
        {
          "id": 0,
          "text": "Patient in remission, MRD not detectable, < 1 leukemia cell in 1,000 BM cells"
        },
        {
          "id": 1,
          "text": "Patient in remission, MRD not detectable, < 1 leukemia cell in 10,000 BM cells"
        },
        {
          "id": 2,
          "text": "Patient in remission, MRD not detectable, < 1 leukemia cell in 100,000 BM cells"
        },
        {
          "id": 3,
          "text": "Patient in remission, MRD not detectable, < 1 leukemia cell in 100,0000 BM cells"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Correct answer is b:</strong> <strong>Patient in remission, MRD not detectable, < 1 <span class=\"customMeta\" data-dictid=\"4521dbf4b91692777191a73002bf98\">leukemia</span> cell in 10,000 BM cells </strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:593px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td colspan=\"2\" style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>Response Parameters According to Minimal Residual Disease (MRD)</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Complete hematologic <span class=\"customMeta\" data-dictid=\"b4a3b8da7716927771975375dadad9\">remission</span> (CHR)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Leukemic cells not detectable by light <span class=\"customMeta\" data-dictid=\"51df8cdfc91692777192aa76f4de51\">microscopy</span> (<5% blast cells in <span class=\"customMeta\" data-dictid=\"5b9831f3aa169277718395d7361df6\">bone marrow</span> [BM])</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Complete molecular remission/MRD negativity</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Patient in complete remission, MRD not detectable, ≤0.01% = <1 <span class=\"customMeta\" data-dictid=\"4521dbf4b91692777191a73002bf98\">leukemia</span> cell in 10,000 BM cells</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following type of ALL is associated with philadelphia chromosome",
      "choices": [
        {
          "id": 0,
          "text": "Common ALL"
        },
        {
          "id": 1,
          "text": "Mature B cell ALL"
        },
        {
          "id": 2,
          "text": "T cell ALL"
        },
        {
          "id": 3,
          "text": "Pro B- ALL"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: Common ALL</strong></p>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:593px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>SUBTYPES</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>INCIDENCE</strong></p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p><strong>FREQUENT CYTOGENETIC ABERRATIONS</strong></p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>B-lineage ALL (B-ALL)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>76%</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p> </p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Pro B-ALL</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>12%</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>t(4;11)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Common ALL</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>49%</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>t(9;22)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Pre-B-ALL</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>11%</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>t(9;22)</p>\n\n\t\t\t<p>t(1;19)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Mature B-ALL</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>4%</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>t(8;14)</p>\n\n\t\t\t<p>t(2;8)</p>\n\n\t\t\t<p>t(8;22)</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>T-lineage ALL (T-ALL)</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>24%</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>t(10;14)</p>\n\n\t\t\t<p>t(11;14)</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "What drugs are used in pre-phase therapy for a patient with Acute lymphoblastic leukemia?",
      "choices": [
        {
          "id": 0,
          "text": "Rasburicase"
        },
        {
          "id": 1,
          "text": "Allopurinol"
        },
        {
          "id": 2,
          "text": "Dexamethasone plus vincristine"
        },
        {
          "id": 3,
          "text": "Dexamethasone plus methotrexate"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Correct answer is c: Dexamethasone plus vincristine </strong></p>\n\n<p>Pre-phase therapy in ALL consists of giving steroids with vincristine or <span class=\"customMeta\" data-dictid=\"a6ed2a5f63169277718507c569e576\">cyclophosphamide</span> for 5-7 days. The advantages are</p>\n\n<ol>\n\t<li>Avoid tumor <span class=\"customMeta\" data-dictid=\"803b5ed1c8169277719190b446ac83\">lysis</span> syndrome</li>\n\t<li>Give time to institute support therapy like PRBC, platelets and treat infections</li>\n\t<li>Lead time for reports of <span class=\"customMeta\" data-dictid=\"3e24b8a74016927771854640e61103\">cytogenetics</span> and molecular <span class=\"customMeta\" data-dictid=\"5374c9f83a16927771887590999974\">genetics</span> to come in</li>\n</ol>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "A 12-year-old boy with relapsed B-cell ALL is planned for therapy with CAR-T cells. In this context, CAR stands for which of the following?",
      "choices": [
        {
          "id": 0,
          "text": "Chimeric Antigen Receptor"
        },
        {
          "id": 1,
          "text": "Chimeric Antibody Receptor"
        },
        {
          "id": 2,
          "text": "Clustered Antigen Receptor"
        },
        {
          "id": 3,
          "text": "Chimeric Antigen Recognition"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: Chimeric Antigen Receptor</strong></p>\n\n<ul>\n\t<li>CAR-T cells are genetically engineered T lymphocytes that express Chimeric Antigen Receptors, enabling them to specifically recognize and kill tumor cells, most often <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> CD19 <strong>i</strong>n B-cell ALL.</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "Which of the following is an anti CD-19 targeting antibody used in acute lymphoblastic leukemia?",
      "choices": [
        {
          "id": 0,
          "text": "Blinatumomab"
        },
        {
          "id": 1,
          "text": "Rituximab"
        },
        {
          "id": 2,
          "text": "Ruxolitinib"
        },
        {
          "id": 3,
          "text": "Dasatinib"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: Blinatumomab </strong></p>\n\n<ul>\n\t<li><strong>Blinatumomab</strong> is a bispecific T-cell engager (BiTE) <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> that binds <strong>CD19</strong> on B-cells and <strong>CD3</strong> on T-cells, redirecting T-cells to kill B-cell blasts in <strong>B-ALL</strong>.</li>\n\t<li><strong>Rituximab</strong> is an Anti-CD20 <span class=\"customMeta\" data-dictid=\"b2b82438d6169277719287eb450079\">monoclonal</span> <span class=\"customMeta\" data-dictid=\"9d7a12cab116927771811a0079086d\">antibody</span> (used in B-cell NHL, CLL).</li>\n\t<li><strong>Ruxolitinib</strong> is a JAK1/JAK2 <span class=\"customMeta\" data-dictid=\"b5fb56a28b1692777190396ae8b625\">inhibitor</span> (used in myelofibrosis, <span class=\"customMeta\" data-dictid=\"7fd466a9c016927771962d5b061b0f\">polycythemia</span> vera, Ph-like ALL with JAK mutations).</li>\n\t<li><strong>Dasatinib</strong> is a TKI <span class=\"customMeta\" data-dictid=\"e4865847fa169277720044d7b530b0\">targeting</span> BCR-ABL (used in CML, Ph+ ALL).</li>\n</ul>\n\n<p> </p>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    },
    {
      "text": "The most common benign tumor in children is?",
      "choices": [
        {
          "id": 0,
          "text": "Hemangioma"
        },
        {
          "id": 1,
          "text": "Acute lymphoblastic lymphoma"
        },
        {
          "id": 2,
          "text": "Cerebellar astrocytoma"
        },
        {
          "id": 3,
          "text": "Medulloblastoma"
        }
      ],
      "correct_choice_id": 0,
      "solution": "<p><strong>Correct answer is a: Hemangioma</strong></p>\n\n<ul>\n\t<li>Most common tumors in children</li>\n</ul>\n\n<table cellspacing=\"0\" style=\"border-collapse:collapse; width:600px\">\n\t<tbody>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Benign overall</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Hemangioma</p>\n\t\t\t</td>\n\t\t</tr>\n\t\t<tr>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Malignant overall</p>\n\t\t\t</td>\n\t\t\t<td style=\"border-bottom:1px solid #000000; border-left:1px solid #000000; border-right:1px solid #000000; border-top:1px solid #000000; vertical-align:top\">\n\t\t\t<p>Acute lymphoblastic leukemia</p>\n\n\t\t\t<p>Brain tumor : medulloblastoma</p>\n\t\t\t</td>\n\t\t</tr>\n\t</tbody>\n</table>",
      "question_images": [],
      "explanation_video": null,
      "explanation_images": [],
      "explanation_audio_eng": null,
      "explanation_audio_hin": null
    }
  ]
}